Bumetanide
"Bumetanide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sulfamyl diuretic.
Descriptor ID |
D002034
|
MeSH Number(s) |
D02.065.884.150 D02.241.223.100.050.300.200 D02.455.426.559.389.127.020.452.500 D02.886.590.700.150
|
Concept/Terms |
Bumex- Bumex
- Roche Brand of Bumetanide
- Bumetanide Roche Brand
Burinex- Burinex
- Leo Brand of Bumetanide
- Bumetanide Leo Brand
- AstraZeneca Brand of Bumetanide
- Bumetanide AstraZeneca Brand
Fordiuran- Fordiuran
- Farmacusi Brand of Bumetanide
- Bumetanide Farmacusi Brand
Miccil- Miccil
- Senosiain Brand of Bumetanide
- Bumetanide Senosiain Brand
Bumedyl- Bumedyl
- Atlantis Brand of Bumetanide
- Bumetanide Atlantis Brand
Drenural- Drenural
- Grossmann Brand of Bumetanide
- Bumetanide Grossmann Brand
|
Below are MeSH descriptors whose meaning is more general than "Bumetanide".
Below are MeSH descriptors whose meaning is more specific than "Bumetanide".
This graph shows the total number of publications written about "Bumetanide" by people in UAMS Profiles by year, and whether "Bumetanide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bumetanide" by people in Profiles over the past ten years.
-
Frye RE. Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents. CNS Drugs. 2018 08; 32(8):713-734.